Enzo Biochem shareholders elect board, approve executive pay
In a recent gathering of its shareholders, Enzo Biochem Inc. (NYSE:ENZ), a medical laboratory services provider with a market capitalization of $35.37 million, concluded several key votes on the ...
Volt Provides Operational Update as it Scales-Up U.S. Lithium Field Operations in Texas ...
Generation 5 Field Unit on track to be operational by late January 2025, with a modular design capable of supporting initial commercial ...